Raffaella’s Literature Update

The following message is courtesy of Dr Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium. Dear Friends,  On 14 May, the WHO released the document “WHO guideline on balanced national controlled medicines policies to ensure medical access and safety: rapid communication” – accessible at https://iris.who.int/bitstream/handle/10665/381452/B09419-eng.pdf?sequence=1 The purpose is ‘to assist WHO Member States ...

WHO Alert: Falsified IMFINZI Detected

World Health Organisation (WHO) warns of falsified IMFINZI (durvalumab) 500mg/10ml found in Iran and Türkiye. These fake cancer treatment products pose serious health risks and may be ineffective. Batches with lot numbers BAZR, BBEG, and AVZT are affected. Healthcare professionals and the public are urged to report any cases and avoid using unlicensed medicines. More ...

AMEX Healthcare is Quamed QCP certified!

On the 28th of April, Quamed issued two QCP certificates to Amex Healthcare. The first one is a QCP MQAS certificate: QCP-MQAS-EN-003. It was issued to AMEX Healthcare GmbH in Austria. They are located at the Heiligenstädter Straße 31/3, Vienna, 1190. The second one is a QCP GSDP certificate: QCP-GSDP-EN-009. It was issued to AMEX ...

Raffaella’s Literature Update

The following message is courtesy of Dr Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium. Ref. WHO Expert Committee on Specifications for Pharmaceutical Preparations: fifty-eight report. Geneva: World Health Organization; 2025 (WHO Technical Report Series, No. 1060). Licence: CC BY-NC-SA 3.0 IGO. Dear friends, The WHO has just published the 58th report of the Expert Committee ...

WHO Finalizes Landmark Pandemic Treaty

Final stretch at the World Health Organisation: a historic pandemic agreement is within reach! After more than 3 years of negotiations, member states are finalising today a crucial treaty to ensure a fairer and more equitable response to future pandemics. Despite compromises, the agreement marks major progress by putting equitable access to treatments and technologies ...

Disampharma GSDP QCP

The DISAMPHARMA GSDP QCP certificate is live! Following our independent decision commission last week, we are happy to present the QCP GSDP certificate for DISAMPHARMA S.L. DISAMPHARMA, a wholesale supplier of health products and medical devices, is based in Colombia. Their website is https://disampharma.com/. We encourage our members and partners to contact them.

DISAMPHARMA QCP certified!

On the 18th of March Quamed’s independent decision commission gave the green light to award a QCP GSDP certificate to DISAMPHARMA S.L. The actual certificate will be issued and shared in a few days from now. DISAMPHARMA is based in Colombia at Calle 23 #116-31 Bod.23, Parque Empresarial Puerto Central, Bogotá. Their website is https://disampharma.com/. DISAMPHARMA is a ...

WHO Issues Alert on Falsified OXYCONTIN 80mg in Europe

The World Health Organization (WHO) has issued a Medical Product Alert for falsified OXYCONTIN 80mg (oxycodone hydrochloride) found in Switzerland. Laboratory testing revealed that the counterfeit tablets contain potent synthetic opioids, likely nitazene compounds, instead of oxycodone, posing a high risk of overdose and death. The falsified product mimics genuine MUNDIPHARMA-manufactured OXYCONTIN from Poland but features incorrect batch and ...

Strengthening Quality Assurance in Medical Procurement

From February 25th to 27th, Quamed successfully facilitated a high-impact training workshop in Addis Ababa, Ethiopia, on “Capacity Building on Quality Assurance in the Procurement of Medical Products”. Organized on behalf of WHO Ethiopia, in collaboration with WHO AFRO and WHO HQ, this training brought together key stakeholders, including Health Cluster Members, the Ethiopian Food ...

Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.